FMEDX
Fidelity Disruptive Medicine Fund
$11.28
Fidelity Disruptive Medicine Fund (FMEDX)
The fund primarily directs at least 80% of its total assets into companies that are leading advancements in the medical sector. Its core investments largely consist of equity instruments. According to the Adviser, "disruptive medicine" companies encompass, but are not limited to, those engaged in fields such as robotic surgical procedures, gene therapy, genomic research, treatments for rare conditions, cutting-edge medical devices and apparatus, immunotherapy, digital healthcare platforms, and initiatives promoting consumer well-being. It is important to note that this fund operates as a non-diversified portfolio.
FMEDX Mutual Fund Chart & Stats
$11.28
At close: 4:00 PM EST- Previous Close
- $11.28
- Total Liabilities
- $494.76K
- Holding Count
- 68
- Brand
- Fidelity Summer Street Trust
- Total Assets
- 43.72M
- Shares Outstanding
- N/A
- 52-Week Range
- $11.28 - $11.28
FMEDX Mutual Fund Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| BSXBoston Scientific | 4.47% |
| UNHUnitedhealth Group Inc. | 4.01% |
| HUMHumana | 3.88% |
| PENPenumbra Inc. | 3.65% |
| VRTXVertex Pharmaceuticals Inc. | 3.63% |
| LLYEli Lilly And Company | 3.56% |
| PODDInsulet | 3.39% |
| DHRDanaher Corporation | 3.20% |
| RPRXRoyalty Pharma PLC | 3.15% |
| MASIMasimo Corp. | 2.92% |
| Total | 35.85% |
Recently Viewed
No data currently available





